ARTV
NASDAQ
US
Artiva Biotherapeutics, Inc. - Common Stock
$6.74
▼ $-0.01
(-0.15%)
Vol 146K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$105.3M
ROE
-50.0%
D/E
0.06
Beta
1.42
52W
$1–$12
Wall Street Consensus
12 analysts · Apr 20264
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating
Price Chart
Similar Stocks
ACHV
Achieve Life Sciences Inc
$264.6M
SGMT
Sagimet Biosciences Inc
$183.5M
CNTN
Canton Strategic Holdings Inc
CNTB
Connect Biopharma Holdings Ltd
$157.6M
PRLD
Prelude Therapeutics Inc
$164.2M
RNAC
Cartesian Therapeutics Inc
$187.5M
WHWK
Whitehawk Therapeutics Inc
$114.1M
NKTX
Nkarta Inc
$131.4M
ABOS
Acumen Pharmaceuticals Inc
$127.8M
VTVT
vTv Therapeutics Inc
$167.1M
Earnings
Beat rate: 40.0%
Next Report
May 06, 2026
EPS Estimate: $-0.89
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.89 | — | — |
| Dec 2025 | $-0.84 | $-0.85 | $-0.01 |
| Sep 2025 | $-0.89 | $-0.88 | +$0.01 |
| Jun 2025 | $-0.82 | $-0.87 | $-0.05 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -42.3% | -41.9% | -42.3% | -42.3% | -50.0% | -50.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 |
| Current Ratio | 13.84 | 13.55 | 13.84 | 13.84 | 11.65 | 11.65 |
Key Ratios
ROA (TTM)
-44.1%
P/B
1.3
EPS (TTM)
$-3.25
Rev Growth 3Y
-50.0%
52W High
$11.55
52W Low
$1.47
$1.47
52-Week Range
$11.55
How does ARTV compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ARTV valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.3
▼
47%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ARTV profitability vs Biotechnology peers
ROE
-50.0%
▲
26%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-44.1%
▲
6%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
ARTV financial health vs Biotechnology peers
D/E ratio
0.1
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
11.7
▲
162%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.4
▲
46%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
ARTV fundamentals radar
ARTV
Peer median
Industry
ARTV profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ARTV vs peers: key metrics
Latest News
No related news yet